La Jolla Pharmaceutical Company
LJPC
LJPC was delisted on the 19th of August, 2022.
71 hedge funds and large institutions have $383M invested in La Jolla Pharmaceutical Company in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 10 closing their positions.
839% more call options, than puts
Call options by funds: $7.65M | Put options by funds: $815K
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
50% more capital invested
Capital invested by funds: $256M → $383M (+$128M)
19% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 21
3% less funds holding
Funds holding: 73 → 71 (-2)
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
PointState Capital
New York
|
+$3.77M |
| 2 |
BC
Broadfin Capital
New York
|
+$3.12M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
+$2.62M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.22M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$678K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$2.78M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.6M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$1.12M |
| 4 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
-$960K |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$852K |
LJPC Hedge Fund Activity: Q3 2016 in Review
71 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical Company (LJPC) for Q3 2016, worth a combined $383M — up 50% from $256M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of LJPC and 8 opened new positions — a net loss of 2 holders — while 21 trimmed existing stakes and 25 added.
The largest buyer was PointState Capital, opening a new position worth an estimated $3.77M. The largest seller was Granahan Investment Management, cutting an estimated $2.78M.
- 71 institutional investors held La Jolla Pharmaceutical Company (LJPC) as of Q3 2016, down from 73 in Q2 2016.
- Funds reported $383M of La Jolla Pharmaceutical Company stock for Q3 2016, up 50% quarter-over-quarter.
- 8 funds opened new La Jolla Pharmaceutical Company positions in Q3 2016 and 10 closed out, a net change of -2 holders.
- The largest La Jolla Pharmaceutical Company buyer in Q3 2016 was PointState Capital, an estimated $3.77M added.
- The largest La Jolla Pharmaceutical Company seller in Q3 2016 was Granahan Investment Management, an estimated $2.78M sold.
Based on aggregated 13F filings for Q3 2016.